TNXPTonix Pharmaceuticals Holding Corp.vs its industry peers
A metric-by-metric comparison of Tonix Pharmaceuticals Holding Corp. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNXPThis | $207M#6 | — | 0.9x#5 | 15.8x#4 | 29.8%#3 | 4.6%#6 | -959.1%#5 | -55.8%#9 | -234.8%#4 | — | -55.5%#5 | — |
| SIGA | $224M#3 | — | 1.4x#8 | 2.4x#3 | -31.8%#5 | -60.7%#11 | 25.1%#2 | 14.1%#3 | — | — | -57.1%#7 | 19.2%#1 |
| ZNTL | $225M#2 | — | 1.6x#9 | — | -100.0%#6 | 17.4%#5 | — | -95.4%#11 | — | — | — | — |
| ELDN | $218M#4 | — | 6.6x#13 | — | — | -26.1%#9 | — | -138.2%#13 | — | — | — | — |
| KROS | $213M#5 | — | 0.8x#3 | 0.9x#2 | 6775.0%#1 | 146.4%#3 | 27.7%#1 | 33.2%#1 | — | — | -31.9%#4 | — |
| BRVE | $2.6B#1 | — | — | — | — | — | — | — | — | — | — | — |
| NKTX | $206M#7 | — | 0.8x#4 | — | — | 4.3%#7 | — | -42.0%#7 | — | — | 47.9%#2 | — |
| KRRO | $204M#8 | — | 2.0x#11 | 31.9x#5 | 181.5%#2 | -40.3%#10 | -1906.4%#6 | -113.6%#12 | -155.2%#3 | — | -55.7%#6 | — |
| ANTX | $202M#9 | — | 2.7x#12 | — | — | 31.5%#4 | — | -46.3%#8 | — | — | 316.0%#1 | — |
| PEPG | $200M#10 | — | 1.7x#10 | — | — | 0.4%#8 | — | -75.0%#10 | — | — | — | — |
| ORMP | $194M#11 | 1.1x#1 | 1.0x#6 | 97.1x#6 | — | 573.1%#2 | -754.4%#4 | 0.0%#4 | -4.4%#2 | — | — | — |
| ORGO | $181M#12 | — | 1.2x#7 | 0.3x#1 | 17.0%#4 | 4011.1%#1 | 7.9%#3 | 25.0%#2 | 23.2%#1 | — | — | — |
| NERV | $167M#13 | — | — | — | — | -20492.7%#13 | — | — | — | — | — | — |
| RNA | $163M#14 | — | 0.8x#2 | — | — | — | — | 0.0%#5 | — | — | — | — |
| CNTN | $162M#15 | — | 0.4x#1 | — | — | -194.5%#12 | — | -7.9%#6 | — | — | -29.3%#3 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice